Quick Answer
Mosaic ImmunoEngineering Inc. reported Operating Income of -$879.7 thousand for fiscal year 2024.
Mosaic ImmunoEngineering Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$879.7K | +37.2% |
| 2023 | -$1.40M | +46.7% |
| 2022 | -$2.63M | +25.0% |
| 2021 | -$3.50M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$144.4K | +22.6% | +3.0% |
| June 30, 2025 | -$148.9K | +45.7% | +14.8% |
| March 31, 2025 | -$174.8K | +35.0% | +6.3% |
| September 30, 2024 | -$186.4K | +40.2% | +32.0% |
| June 30, 2024 | -$274.3K | +22.2% | -2.1% |
| March 31, 2024 | -$268.8K | +41.5% | +13.8% |
| September 30, 2023 | -$311.9K | +39.7% | +11.5% |
| June 30, 2023 | -$352.5K | +60.1% | +23.3% |
- Mosaic ImmunoEngineering Inc. showed an increase of +37.2% in Operating Income compared to the prior fiscal year.
- Over the 2021–2024 period, Mosaic ImmunoEngineering Inc.’s operating income has grown by 74.9% (from -$3.50 million to -$879.7 thousand).
- The most recent figure is from Mosaic ImmunoEngineering Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: